Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro antibiotic susceptibility testing of different strains of Mycoplasma fermentans isolated from a variety of sources.

Literature DB >> 8285644

In vitro antibiotic susceptibility testing of different strains of Mycoplasma fermentans isolated from a variety of sources.

M M Hayes¹, H H Foo, H Kotani, D J Wear, S C Lo.

Abstract

The in vitro susceptibilities to antibiotics of 24 strains of Mycoplasma fermentans (isolated from human immunodeficiency virus type 1-infected AIDS patients, non-AIDS patients with acute respiratory disease, and tissue culture) were determined. MICs for 90% of the strains tested (micrograms per milliliter) were obtained for chloramphenicol (1.25), ciprofloxacin (0.078), clindamycin (0.078), doxycycline (0.625), erythromycin (> 10), gentamicin (> 10), levofloxacin (0.078), lincomycin (0.156), streptomycin (> 10), and tetracycline (0.625).

Entities: Disease Species

Mesh：

Substances：
Anti-Bacterial Agents

Year: 1993 PMID： 8285644 PMCID： PMC192419 DOI： 10.1128/AAC.37.11.2500

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

23 in total

1. Identification of Mycoplasma incognitus infection in patients with AIDS: an immunohistochemical, in situ hybridization and ultrastructural study.

Authors: S C Lo; M S Dawson; D M Wong; P B Newton; M A Sonoda; W F Engler; R Y Wang; J W Shih; H J Alter; D J Wear
Journal: Am J Trop Med Hyg Date: 1989-11 Impact factor: 2.345

2. Virus-like infectious agent (VLIA) is a novel pathogenic mycoplasma: Mycoplasma incognitus.

Authors: S C Lo; J W Shih; P B Newton; D M Wong; M M Hayes; J R Benish; D J Wear; R Y Wang
Journal: Am J Trop Med Hyg Date: 1989-11 Impact factor: 2.345

3. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).

Authors: K Alestig
Journal: Scand J Infect Dis Suppl Date: 1990

4. In vitro antimicrobial susceptibility testing for the newly identified AIDS-associated Mycoplasma. Mycoplasma fermentans (incognitus strain).

Authors: M M Hayes; D J Wear; S C Lo
Journal: Arch Pathol Lab Med Date: 1991-05 Impact factor: 5.534

5. Comparison of methods for in vitro testing of susceptibility of porcine Mycoplasma species to antimicrobial agents.

Authors: E A Ter Laak; A Pijpers; J H Noordergraaf; E C Schoevers; J H Verheijden
Journal: Antimicrob Agents Chemother Date: 1991-02 Impact factor: 5.191

6. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma.

Authors: S C Lo; S Tsai; J R Benish; J W Shih; D J Wear; D M Wong
Journal: Science Date: 1991-03-01 Impact factor: 47.728

7. Histopathology and doxycycline treatment in a previously healthy non-AIDS patient systemically infected by Mycoplasma fermentans (incognitus strain).

Authors: S C Lo; C L Buchholz; D J Wear; R C Hohm; A M Marty
Journal: Mod Pathol Date: 1991-11 Impact factor: 7.842

8. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.

Authors: K B Waites; L B Duffy; T Schmid; D Crabb; M S Pate; G H Cassell
Journal: Antimicrob Agents Chemother Date: 1991-06 Impact factor: 5.191

9. Association of mycoplasma and human immunodeficiency virus infection: detection of amplified Mycoplasma fermentans DNA in blood.

Authors: R E Hawkins; L S Rickman; S H Vermund; M Carl
Journal: J Infect Dis Date: 1992-03 Impact factor: 5.226

10. Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines.

Authors: M Lemaître; Y Henin; F Destouesse; C Ferrieux; L Montagnier; A Blanchard
Journal: Infect Immun Date: 1992-03 Impact factor: 3.441

8 in total

8. Feeding bovine milks with low or high IgA levels is associated with altered re-establishment of murine intestinal microbiota after antibiotic treatment.

Authors: Alison J Hodgkinson; Wayne Young; Julie A Cakebread; Brendan J Haigh
Journal: PeerJ Date: 2016-09-29 Impact factor: 2.984

8 in total

In vitro antibiotic susceptibility testing of different strains of Mycoplasma fermentans isolated from a variety of sources.

1. Identification of Mycoplasma incognitus infection in patients with AIDS: an immunohistochemical, in situ hybridization and ultrastructural study.

2. Virus-like infectious agent (VLIA) is a novel pathogenic mycoplasma: Mycoplasma incognitus.

3. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).

4. In vitro antimicrobial susceptibility testing for the newly identified AIDS-associated Mycoplasma. Mycoplasma fermentans (incognitus strain).

5. Comparison of methods for in vitro testing of susceptibility of porcine Mycoplasma species to antimicrobial agents.

6. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma.

7. Histopathology and doxycycline treatment in a previously healthy non-AIDS patient systemically infected by Mycoplasma fermentans (incognitus strain).

8. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.

9. Association of mycoplasma and human immunodeficiency virus infection: detection of amplified Mycoplasma fermentans DNA in blood.

10. Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines.

1. Pathogenicity of Mycoplasma fermentans and Mycoplasma penetrans in experimentally infected chicken embryos.

2. In vitro antibiotic susceptibility testing of clinical isolates of Mycoplasma penetrans from patients with AIDS.

3. Peptide methionine sulfoxide reductase (MsrA) is a virulence determinant in Mycoplasma genitalium.

4. In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.

5. Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation.

6. Antibiotic susceptibilities of AIDS-associated mycoplasmas.

7. Biological enrichment of Mycoplasma agents by cocultivation with permissive cell cultures.

8. Feeding bovine milks with low or high IgA levels is associated with altered re-establishment of murine intestinal microbiota after antibiotic treatment.